BioCentury
ARTICLE | Financial News

BioBlast Pharma proposes follow-on

March 2, 2017 1:16 AM UTC

On Feb. 24, rare disease play BioBlast Pharma Ltd. (NASDAQ:ORPN) proposed to raise up to $11.5 million in a follow-on underwritten by H.C. Wainwright....

BCIQ Company Profiles

BioBlast Pharma Ltd.